Skip to main content

Table 3 Total and Free Serum Isoflavones and Androgen Receptor CAG repeat

From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Patient No.

Total Genistein (μg/ml)

Total Daidzein (μg/ml)

Total Equol (μg/ml)

Androgen Receptor CAG repeat

1

0.709

0.735

0.115

21

2

1.284

0.660

0.063

26

3

0.189

0.468

0.331

21

4

0.555

0.409

0.306

21

5

0.102

0.572

0.523

13

6

0.739

0.468

0.039

16

7

2.071

0.602

0.329

20

8

N/A

N/A

N/A

30

9

0.022

0.014

0.020

21

10

N/A

N/A

N/A

24

11

0.023

0.568

<0.001

16

12

0.186

0.063

0.061

16

13

<0.002

0.005

0.048

19

14

0.058

0.192

0.050

21

15

1.049

0.580

0.188

21

16

0.492

0.170

0.062

17

17

1.989

0.817

0.492

24

18

<0.002

0.021

0.119

19

19

N/A

N/A

N/A

N/A

20

N/A

N/A

N/A

N/A

Median

0.524

0.468

0.115

---

  1. N/A, not assessed (adequate sample unable to be obtained)
  2. μg, microgram
  3. mL, milliliter
  4. MW, molecular weight